Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Revenue

In the year 2025, Corline Biomedical AB had annual revenue of 8.59M SEK, down -50.29%. Corline Biomedical AB had revenue of 2.15M in the quarter ending December 31, 2025, a decrease of -12.19%.

• Revenue: 8.59M
• Revenue Growth: -50.29%
• P/S Ratio: 47.28
• Revenue / Employee: 715.50K
• Employees: 13
• Market Cap: 405.97M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.59M	-8.69M	-50.29%
Dec 31, 2024	17.27M	-18.25M	-51.37%
Dec 31, 2023	35.52M	2.93M	8.98%
Dec 31, 2022	32.59M	15.40M	89.55%
Dec 31, 2021	17.19M	2.12M	14.05%